Detalhe da pesquisa
1.
KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target.
Blood
; 140(13): 1522-1532, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687761
2.
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
Lancet Oncol
; 20(8): 1160-1170, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253572
3.
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
Haematologica
; 108(10): 2830-2836, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165836
4.
Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2 T cells increase resistance to tuberculosis in nonhuman primates.
PLoS Pathog
; 9(8): e1003501, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23966854
5.
Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
Cytometry A
; 85(10): 869-82, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25044837
6.
KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting.
Blood
; 130(26): 2900-2902, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29089310
7.
The PPARα pathway in Vγ9Vδ2 T cell anergy.
Cell Mol Biol Lett
; 19(4): 649-58, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25424910
8.
Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate.
Biomolecules
; 14(1)2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38275765
9.
gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes.
J Immunol
; 184(1): 134-40, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19949101
10.
Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection.
Blood
; 113(4): 837-45, 2009 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981295
11.
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.
Blood
; 113(20): 4875-84, 2009 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19278954
12.
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors.
Cancer Immunol Immunother
; 59(10): 1521-30, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20563721
13.
Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate.
J Med Chem
; 51(6): 1747-54, 2008 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18303828
14.
Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome.
Clin Cancer Res
; 23(14): 3619-3627, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28119365
15.
CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214.
Arch Dermatol Res
; 309(1): 11-19, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27766406
16.
A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies.
Oncoimmunology
; 4(9): e1022306, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26405593
17.
IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma.
Cancer Res
; 74(21): 6060-70, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361998
18.
In vivo interferon-alpha/ribavirin treatment modulates Vγ9Vδ2 T-cell function during chronic HCV infection.
J Interferon Cytokine Res
; 33(3): 136-41, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23308376
19.
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
Cell Mol Immunol
; 10(1): 35-41, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23241899
20.
In vivo manipulation of γ9(+) T cells in the common marmoset (Callithrix Jacchus) with phosphoantigen and effect on the progression of respiratory melioidosis.
PLoS One
; 8(9): e74789, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24098670